The DOI matches its Crossref record.
Isolation of a Cytopathogenic Agent from Human Adenoids Undergoing Spontaneous Degeneration in Tissue Culture
Abstract
1. From the present evidence it appears that an unidentified, possibly new, tissue culture cytopathogenic agent has been isolated repeatedly from human adenoids undergoing spontaneous degeneration in tissue culture. The filter ability and the inability to cultivate the agent on bacteriological media and to demonstrate organisms in stained tissue culture preparations would indicate that the agent belongs to the group of viruses or rickettsial It is tentatively proposed to designate the agent as the “adenoid degeneration agent”, abbreviated as “A.D. agent”. 2. That the agent is derived from the adenoid tissue rather than from the nutrient media is indicated by the fact that some adenoids and all human embryonic tissues cultivated in the identical media and at the same time have not undergone degeneration, although they are susceptible to infection with the agent; also, repeated attempts to isolate the agents from adenoid cultures not demonstrating degeneration have been uniformly unsuccessful. 3. Further investigation is in progress to determine the relation of the agent to the adenoids and to study their possible role in human disease; particularly upper respiratory infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Adenovirus Infections in Immunocompetent and Immunocompromised Patients
Lion, T. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-13 · Cited by 861
Fong, T.-T., & Lipp, E. K. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.357-371.2005 · Cited by 795
Update on adenovirus and its vectors
Russell, W. C. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2573 · Cited by 596
Chapter 8 Use of Recombinant Adenovirus for Metabolic Engineering of Mammalian Cells
Becker, T. C., Noel, R. J., Coats, W. S., Gómez-Foix, A. M., Alam, T., Gerard, R. D., & Newgard, C. B. (1994) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60603-2 · Cited by 569
New Adenovirus Species Found in a Patient Presenting with Gastroenteritis
Jones, M. S., Harrach, B., Ganac, R. D., Gozum, M. M. A., dela Cruz, W. P., Riedel, B., Pan, C., Delwart, E. L., & Schnurr, D. P. (2007) · Journal of Virology · doi:10.1128/jvi.02650-06 · Cited by 384
Stewart, P. L., Fuller, S. D., & Burnett, R. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05919.x · Cited by 381
Gene Therapy Leaves a Vicious Cycle
Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00297 · Cited by 347
The impact of adenovirus infection on the immunocompromised host
Kojaoghlanian, T., Flomenberg, P., & Horwitz, M. S. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.386 · Cited by 333
Oncolytic viruses in cancer therapy
Vähä-Koskela, M. J. V., Heikkilä, J. E., & Hinkkanen, A. E. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.02.002 · Cited by 333
Prevalence and Quantitation of Species C Adenovirus DNA in Human Mucosal Lymphocytes
Garnett, C. T., Erdman, D., Xu, W., & Gooding, L. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10608-10616.2002 · Cited by 328
Human adenovirus: Viral pathogen with increasing importance
Ghebremedhin, B. (2014) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.4.2014.1.2 · Cited by 327
Viral gene therapy strategies: from basic science to clinical application
Young, L. S., Searle, P. F., Onion, D., & Mautner, V. (2006) · The Journal of Pathology · doi:10.1002/path.1896 · Cited by 313
Pathogenic Human Viruses in Coastal Waters
Griffin, D. W., Donaldson, K. A., Paul, J. H., & Rose, J. B. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.129-143.2003 · Cited by 294
Molecular composition of the adenovirus type 2 virion
van Oostrum, J., & Burnett, R. M. (1985) · Journal of Virology · doi:10.1128/jvi.56.2.439-448.1985 · Cited by 294
Role of early region 3 (E3) in pathogenesis of adenovirus disease.
Ginsberg, H. S., Lundholm-Beauchamp, U., Horswood, R. L., Pernis, B., Wold, W. S., Chanock, R. M., & Prince, G. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3823 · Cited by 290
Image reconstruction reveals the complex molecular organization of adenovirus
Stewart, P. L., Burnett, R. M., Cyrklaff, M., & Fuller, S. D. (1991) · Cell · doi:10.1016/0092-8674(91)90578-m · Cited by 285
Molecular Epidemiology of Human Adenoviruses
Wadell, G. (1984) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-46494-2_7 · Cited by 276
Clinical features and treatment of adenovirus infections
Lenaerts, L., De Clercq, E., & Naesens, L. (2008) · Reviews in Medical Virology · doi:10.1002/rmv.589 · Cited by 255
Current Advances and Future Challenges in Adenoviral Vector Biology and Targeting
Campos, S., & Barry, M. (2007) · Current Gene Therapy · doi:10.2174/156652307780859062 · Cited by 210
Advances in Gene Delivery Systems
Kamimura, K., Suda, T., Zhang, G., & Liu, D. (2011) · Pharmaceutical Medicine · doi:10.1007/bf03256872 · Cited by 124
Implications of the Innate Immune Response to Adenovirus and Adenoviral Vectors
Gregory, S. M., Nazir, S. A., & Metcalf, J. P. (2011) · Future Virology · doi:10.2217/fvl.11.6 · Cited by 89
Are adenoviruses zoonotic? A systematic review of the evidence
Borkenhagen, L. K., Fieldhouse, J. K., Seto, D., & Gray, G. C. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1690953 · Cited by 79
Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors
Lopez-Gordo, E., Podgorski, I. I., Downes, N., & Alemany, R. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.228 · Cited by 65
Metadata
- Authors
- Rowe, W. P., Huebner, R. J., Gilmore, L. K., Parrott, R. H., & Ward, T. G.
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 1953-12-01
- Volume
- 84
- Issue
- 3
- Pages
- 570-573
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2328476123
- Cited by
- 1,114
- References
- 0
- FWCI
- 60.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.